SCTR regulates cell cycle-related genes toward anti-proliferation in normal breast cells while having

Seongeun Kang1, Byungtak Kim1, Han-Sung Kang2

  • 1Department of Life Science, Dongguk University-Seoul, Goyang, Republic of Korea.

Insights

Secretin receptor (SCTR) methylation downregulates SCTR in breast cancer, suppressing normal cell growth. However, SCTR overexpression stimulates cancer cell proliferation and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Secretin receptor (SCTR), a G-protein coupled receptor (GPCR), exhibits varied expression in tumors, influencing cancer cell proliferation.
  • The molecular mechanisms behind SCTR dysregulation in cancer remain largely unelucidated.

Purpose of the Study:

  • To investigate the role of SCTR methylation in breast cancer and its impact on cell proliferation and migration.
  • To understand the regulatory mechanisms of SCTR dysregulation in breast cancer.

Main Methods:

  • Methylome database analysis in breast cancer to identify affected pathways.
  • siRNA-mediated downregulation of SCTR in MCF-10A cells followed by pathway analysis.
  • Overexpression of SCTR in MCF-7 cells to assess effects on proliferation and migration.

Main Results:

  • SCTR demonstrated hypermethylation and downregulation in breast cancer tissues (p<0.01 and p<0.05, respectively).
  • Downregulation of SCTR in normal breast cells (MCF-10A) affected the G2/M stage checkpoint and cell cycle genes, suppressing proliferation.
  • SCTR overexpression in breast cancer cells (MCF-7) increased proliferation by 35% and migration by 2.1-fold.

Conclusions:

  • SCTR promoter methylation leads to its downregulation in breast cancer, which suppresses normal breast cell proliferation.
  • Conversely, SCTR stimulates proliferation and migration in breast cancer cells, suggesting a dual role dependent on its expression level and cellular context.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K